| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/05/2011 | US7972798 Method for identifying diabetic patients at increased risk for pathological complications |
| 07/05/2011 | US7972780 ITPase gene polymorphisms associated with adverse drug reactions to azathioprine therapy |
| 07/05/2011 | US7972777 Nucleic acid probe-based diagnostic assays targeting ssrA genes of prokaryotic and eukaryotic organisms |
| 07/05/2011 | US7972772 KIF11 and method for diagnosing non-small cell lung cancer |
| 07/05/2011 | US7972631 Physiological tissue repair and functional organ regeneration by cultivation of regenerative stem cells in vivo and in situ |
| 07/05/2011 | US7972630 Injectable bone mineral substitute material |
| 07/05/2011 | US7972627 Beclomethasone powders has specific particle size distribution; increase bioavailability, prolonged therapeutic effect of the drug substance; aqueous suspension for inhalation; drug delivery method and device; rhinitis treatment |
| 07/05/2011 | US7972626 Fluticasone powders has specific particle size distribution; increase bioavailability, prolonged therapeutic effect of the drug substance; aqueous suspension for inhalation; drug delivery method and device; rhinitis treatment |
| 07/05/2011 | US7972624 Method of manufacturing modified release dosage forms |
| 07/05/2011 | US7972612 Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker |
| 07/05/2011 | US7972600 IGF-IR antagonists as adjuvants for treatment of prostate cancer |
| 07/05/2011 | US7972595 Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analog |
| 07/05/2011 | US7972137 Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease |
| 07/05/2011 | DE202011004857U1 Arznei- oder Nahrungsergänzungsmittel zur Behandlung und/oder Prophylaxe von Knochenerkrankungen Medicinal or dietary supplement for the treatment and / or prophylaxis of bone disease |
| 07/05/2011 | CA2689080C Treating benign prostate hyperplasia with sarms |
| 07/05/2011 | CA2660818C Antibacterial agent and therapeutic agent for johne's disease containing the same |
| 07/05/2011 | CA2649844C Pharmacological modulation of positive ampa receptor modulator effects on neurotrophin expression |
| 07/05/2011 | CA2634055C Antitussive agent |
| 07/05/2011 | CA2630269C Inhibitors of diacyglycerol acyltransferase (dgat) |
| 07/05/2011 | CA2627038C Beverage |
| 07/05/2011 | CA2622879C Use of a3 adenosine receptor agonist in osteoarthritis treatment |
| 07/05/2011 | CA2616695C Transdermal system for varenicline |
| 07/05/2011 | CA2606147C Apoptosis promoters |
| 07/05/2011 | CA2601098C Dipyrazoles as central nervous system agents |
| 07/05/2011 | CA2600409C Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds |
| 07/05/2011 | CA2583907C Heteroaryl-substituted alkyne compounds and method of use |
| 07/05/2011 | CA2577247C Method for manufacturing enantiomeric imidazole compounds |
| 07/05/2011 | CA2564563C Indolyl derivatives as liver-x-receptor modulators |
| 07/05/2011 | CA2555064C A pharmaceutical composition |
| 07/05/2011 | CA2533434C Artificial cpg single-stranded oligodeoxynucleotide and antiviral use thereof |
| 07/05/2011 | CA2531484C Novel bioisosteres of actinonin |
| 07/05/2011 | CA2531445C Method for treating irritable bowel syndrome using laxatives |
| 07/05/2011 | CA2526754C Composition and foods for lowering glycemic index |
| 07/05/2011 | CA2517571C Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 07/05/2011 | CA2510175C 1-n-phenylamino-1h-imidazole derivatives and pharmaceutical compositions containing them |
| 07/05/2011 | CA2506242C 4-tetrazolyl-4phenylpiperidine derivatives for treating pain |
| 07/05/2011 | CA2504886C Synthetic lactone formulations and method of use |
| 07/05/2011 | CA2504872C Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections |
| 07/05/2011 | CA2503884C Cyclic sulfamides for inhibition of gamma-secretase |
| 07/05/2011 | CA2499574C Controlled release preparation |
| 07/05/2011 | CA2496469C Topical emulsion-gel composition comprising diclofenac sodium |
| 07/05/2011 | CA2496194C Phenyl-substituted pyrazolopyrimidines |
| 07/05/2011 | CA2489456C Gangliosides with a modified acyl function |
| 07/05/2011 | CA2488630C Immunoadhesin comprising a glycoprotein vi domain |
| 07/05/2011 | CA2487600C Adsorbents for immunosuppressive substance, extracorporeal perfusion columns and methods for treating cancer |
| 07/05/2011 | CA2486728C Novel physiologically active substances useful for suppressing vegf production |
| 07/05/2011 | CA2486090C Pyridine carboxamide derivatives and their use as pesticides |
| 07/05/2011 | CA2483228C Carboxamides |
| 07/05/2011 | CA2483205C Hyperforin derivatives, the use thereof and formulations containing them |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/05/2011 | CA2475586C Novel boronate esters |
| 07/05/2011 | CA2473663C Ubiquinone-enriched foods |
| 07/05/2011 | CA2470668C 5ht4 partial agonist pharmaceutical compositions |
| 07/05/2011 | CA2461625C Use of irbesartan for the preparation of medicinal products that are useful for preventing or treating pulmonary hypertension |
| 07/05/2011 | CA2459172C Bicyclic compound, production and use thereof |
| 07/05/2011 | CA2457319C Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs |
| 07/05/2011 | CA2450466C 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 07/05/2011 | CA2448025C Use of cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders |
| 07/05/2011 | CA2446136C Pyruvate derivatives |
| 07/05/2011 | CA2440160C Antitumor compositions containing taxane derivatives |
| 07/05/2011 | CA2439099C Anti-platelet and anti-thrombotic agents |
| 07/05/2011 | CA2436462C Inhibitors of cruzipain and other cysteine proteases |
| 07/05/2011 | CA2423279C Phthalazinone derivatives |
| 07/05/2011 | CA2421042C The use of tiagabine for treatment of diabetic neuropathy and migraine |
| 07/05/2011 | CA2406968C Method of controlling zoological and aquatic plant growth |
| 07/05/2011 | CA2405767C Pharmaceutical formulations for dry powder inhalers |
| 07/05/2011 | CA2400185C Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
| 07/05/2011 | CA2398772C Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 07/05/2011 | CA2259033C New guanidine derivatives, methods of preparing them and their use as drugs |
| 07/05/2011 | CA2217745C Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 07/05/2011 | CA2190290C A method of inducing an immune response using vaccinia virus recombinants |
| 06/30/2011 | WO2011079327A1 Analogues for the treatment or prevention of flavivirus infections |
| 06/30/2011 | WO2011079315A1 Tyrosine bioconjugation through aqueous ene-like reactions |
| 06/30/2011 | WO2011079313A1 Novel ergoline analogs |
| 06/30/2011 | WO2011079305A1 Therapeutic compounds |
| 06/30/2011 | WO2011079291A1 Radiopharmaceutical complexes |
| 06/30/2011 | WO2011079279A2 Nanoconjugates and nanoconjugate formulations |
| 06/30/2011 | WO2011079274A1 Aminopyrimidine kinase inhibitors |
| 06/30/2011 | WO2011079273A2 Methods and compositions for cardiovascular diseases and conditions |
| 06/30/2011 | WO2011079263A2 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2 |
| 06/30/2011 | WO2011079261A2 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
| 06/30/2011 | WO2011079249A2 Use of vitamin d glycosides and sulfates for treatment of disease |
| 06/30/2011 | WO2011079248A1 Pharmaceutical compositions for deterring misuse, abuse, and diversion |
| 06/30/2011 | WO2011079245A1 Targeted radiolabeled compounds and their use for the treatment and diagnosis of cancer |
| 06/30/2011 | WO2011079236A1 Compositions and methods for cancer detection and treatment |
| 06/30/2011 | WO2011079234A2 Highly permeating terbinafine formulation |
| 06/30/2011 | WO2011079232A1 Sustained release delivery devices |
| 06/30/2011 | WO2011079230A2 Heterocyclic compounds as janus kinase inhibitors |
| 06/30/2011 | WO2011079213A2 Treating critically ill patients with intravenous ibuprofen |
| 06/30/2011 | WO2011079193A2 Preparation of bendamustine and its salts |
| 06/30/2011 | WO2011079154A1 Compositions and methods for treatment of vitiligo |
| 06/30/2011 | WO2011079142A2 Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same |
| 06/30/2011 | WO2011079133A2 Compounds and methods for kinase modulation, and indications therefor |
| 06/30/2011 | WO2011079127A1 Abt-263 capsule |
| 06/30/2011 | WO2011079123A1 Method of reducing incidence of intraocular pressure associated with intraocular use of corticosteroids |
| 06/30/2011 | WO2011079119A1 Formulation comprising 1 h - quinazoline - 2, 4 - dione ampa receptor antagonists, in the form of immediate release tablets and preparation thereof |
| 06/30/2011 | WO2011079118A1 Pteridinones as inhibitors of polo-like kinase |
| 06/30/2011 | WO2011079114A1 Pteridinones as inhibitors of polo - like kinase |
| 06/30/2011 | WO2011079103A1 Spiropiperidine benzylamines as beta-tryptase inhibitors |